Susana Martinez-Conde | Director, Laboratory of Integrative Neuroscience | State University of NY
“Keeping an Eye Out for Collaboration”
Inn at Ole Miss Ballroom A, B, C, D;
10:25 – 11:15 am
Susana Martinez-Conde is a Professor of Ophthalmology, Neurology, and Physiology & Pharmacology at the State University of New York (SUNY) Downstate Medical Center, where her research program bridges perceptual, oculomotor, and cognitive neuroscience. She directed laboratories previously at the Barrow Neurological Institute in Phoenix and at University College London in the UK. She received her postdoctoral training from Nobel Laureate Prof. David Hubel at Harvard Medical School, where she was later an Instructor in Neurobiology. Prof. Martinez-Conde received the Empire Innovator Award from the State of New York. Her work with Parkinsonian patients was honored with the EyeTrack Award, a global science prize given annually to a single cutting-edge publication in eye movement research.
Prof Martinez-ConProfde has received various other distinctions, including the “100 Spaniards” Prize. She complements her award-winning research with science communication, education and public outreach. She writes for Scientific American and has a regular column in Scientific American: MIND on the neuroscience of illusion. Prof. Martinez-Conde is the 2014 recipient of the Science Educator Award, given by the Society for Neuroscience to an outstanding neuroscientist who has made significant contributions to educating the public. Prof. Martinez-Conde’s research has been featured in print in The New York Times, The New Yorker, The Wall Street Journal, Wired, The LA Chronicle, The Times (London), The Chicago Tribune, The Boston Globe, Der Spiegel, etc., and in radio and TV shows, including Discovery Channel’s Head Games and Daily Planet shows, NOVA: ScienceNow, CBS Sunday Morning, NPR’s Science Friday, and PRI’s The World. She works with international science museums, foundations and nonprofit organizations to promote neuroscience education and communication. Her international bestselling book ‘Sleights of Mind’ was published in 21 languages, listed as one of the 36 Best Books of 2011 by The Evening Standard, London, and received the Prisma Prize to the best science book of the year.
“Bedside to Bench: An Accelerated Pharmaceutical Development Program”
The Inn at Ole Miss Ballrooms A, B, C, D
2:20 pm – 2:50 pm
The traditional bench to bedside approach to discover new pharmaceutical products is a high-risk endeavor taking over 10 years and costing hundreds of millions of dollars. Despite significant advancements in pharmaceutical sciences over the past few decades it is estimated that 1 in 10,000 new compounds will make it to the market, the same success rate as in the 1980s. The pharmaceutical industry has evolved over that time to be less research focused and more market focused. Programs such as repurposing of old drugs and life cycle management are increasingly diverting resources from new drug discovery programs. Examples of the types of programs will be presented with an emphasis on meeting patient needs.
Although significant resources have been spent on new drug discovery on the Oxford and Jackson campus no active pharmaceutical ingredients discovered at the university have been commercialized. A “Bedside to Bench” program initiated in the School of Pharmacy will be presented as a complementary program to the current drug discovery effort. This program starts with a clinical observation (“bedside”) that is reported by the clinician in real time using a secured database. Example clinical observations include significant side effects, the need for a new combination drug product, and the need for an alternative route of administration. A team of pharmaceutical scientists (“bench”) reviews the clinical observation and brainstorms potential solutions to address the clinical observation. Examples of ongoing projects will be presented including two projects in which patent rights were licensed to pharmaceutical companies for development.
1. Walter G Chambliss, Ph.D., is Director of Technology Management, Professor of Pharmaceutics and Drug Delivery, at UM.
2. Soumyajit Majumdar, Ph.D., is Associate Dean for Research and Graduate Programs, Professor of Pharmaceutics and Drug Delivery at UM.
3. Daniel M. Riche, Pharm.D., is Associate Professor, Pharmacy Practice, at UMMC.